The o2h Biology Match Funding Award is an exclusive programme designed to help biotechs and pharmaceutical companies accelerate their discovery research projects. With this initiative, o2h Discovery will match-fund 50% of project costs, up to $65,000 (£50,000), enabling companies to achieve critical milestones and advance to the next stage of funding or secure additional grants.
This programme provides access to o2h’s integrated drug discovery expertise, leveraging state-of-the-art research facilities in Cambridge, UK, and Ahmedabad, India. It offers comprehensive biology services, including target discovery and validation, target engagement, assay development, and drug screening using advanced biophysical, biochemical, and cell-based assay platforms. The initiative aims to speed up design-make-test-analyse cycles for structure-activity relationships (SAR) and deepen understanding of mechanisms of action (MOA), propelling drug discovery programs forward.
o2h’s highly qualified team of PhDs and drug discovery experts collaborates across all stages of development, offering bespoke assay development and expertise in areas like PROTACs, RNA therapeutics, integrin biology, and mitochondrial biology. Supported by cutting-edge technology, o2h ensures impactful scientific results, fostering a collaborative environment that drives breakthroughs and supports growth within the biotech ecosystem.
Learn more here